Dark
Streaming/Mobile
Old Site
Home
Products
Help
Contact Us
Your Account
System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
10:03:15 EDT Thu 02 May 2024
Quotes
Streaming/Mobile
Quick Quotes (x20)
Symbol Search
Company Search
Market Depth
US Options
Montreal Options
Foreign Exchange
Download Close Prices
Short History
Quotes Help
Charts
12 Month Chart
Advanced Chart
Live Intraday Chart
Live Historical Chart
Live Java Intraday Chart
Live Java Historical Chart
Charts Help
News
News Search
SEDAR Search
SEDAR Alerts
News Help
Indexes
Major Indexes
US incl Dow Jones
NASDAQ
S&P CME
PBOT - Phil Ex
TSX - Toronto
TSX-V - TSX Venture
Indexes Help
Portfolio
View Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Value Portfolio
All Portfolios
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Edit Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Chart Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
Live Portfolio
Portfolio 1
Portfolio 2
Portfolio 3
Portfolio 4
Portfolio 5
Portfolio 6
Portfolio 7
Portfolio 8
Portfolio 9
Portfolio 10
View Portfolio News
Daily Summary
Portfolio Help
Analytics
Exchange Statistics
Most Active
Live Most Active
Block Trades
Broker Trades
Halted Stocks
Dividends
Participants
Companies
Trade Workstation
Company Picker
Short Positions
Broker Codes
Analytics Help
Mutual Funds
Mutual Fund Search
Targeted Holder Search
SEDAR Fund Search
Mutual Fund Help
Enter Symbol
or Name
USA
CA
Quote
Chart
News
Closes
Depth
Forgot password?
Trouble logging in?
Login to Stockwatch
Q:RDHL
- REDHILL BIOPHARMA LTD SPON ADS EACH REP 400 ORD (POST REV SP -
http://www.redhillbio.com
10:03:15 EDT
Sym-X
Bid - Ask
Last
Chg
%Ch
Vol
$Vol
#Tr
Open-Hi-Lo
Year Hi-Lo
Last Tr
News
Delay
RDHL
- Q
2.0
0.453
·
0.4599
2.6
0.453
+0.003
0.7
16.6
6
36
0.46
0.46
0.453
3.28 0.257
09:42:43
Apr 24
15 min
RT 2¢
Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands.
Nasdaq Indicators -- Market:
Nasdaq
-- Bid Tick:
Up
-- UPC Restricted:
No
Financial Status:
Deficient: Issuer Failed to Meet NASDAQ Continued Listing Requirements
Fundamentals
·
Holders
·
Trade Workstation
·
Market Depth
·
3 Month Closes
·
Technical Charts
1 yr
|
2 yr
|
3 yr
|
5 yr
|
10 yr
|
15 yr
|
20 yr
·
Live Charts
1 yr
|
1 day
·
1yr Bulletins
·
Historical
·
Options
·
Portfolio
Recent Trades - Last 10 of 36
More trades...
Time ET
Ex
Price
Change
Volume
09:42:43
Q
0.4565
0.0055
1
09:42:24
Q
0.4565
0.0055
3
09:35:46
Q
0.4562
0.0052
40
09:35:07
Q
0.453
0.003
400
09:35:01
Q
0.453
0.003
300
09:35:01
Q
0.453
0.003
200
09:35:01
Q
0.453
0.003
300
09:35:01
Q
0.453
0.002
58
09:35:01
Q
0.453
0.003
200
09:35:01
Q
0.453
0.003
500
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
Recent Bulletins
News Releases
In The News
Other
Date ET
Symbol
Type
Headline
2024-04-24 07:00
U:RDHL
News Release
200
RedHill Announces First Patient Enrolled in U.S. Government-Supported COVID-19 Study
2024-04-08 09:23
U:RDHL
News Release
200
RedHill Biopharma Announces Full-Year 2023 Results and Operational Highlights
2024-04-02 07:00
U:RDHL
News Release
200
RedHill Biopharma Announces $1.25 Million Registered Direct Offering at a Premium to Market Price
2024-03-11 07:00
U:RDHL
News Release
200
RedHill Announces New USPTO Patent Covering Talicia(TM) Through 2034
2024-03-05 07:00
U:RDHL
News Release
200
RedHill's Opaganib Selected for Evaluation by BARDA and NIH Countermeasures Programs
2024-02-20 07:00
U:RDHL
News Release
200
RedHill's Opaganib Protects Against Radiation-Induced Lung Inflammation and Fibrosis - New Publication
2024-01-26 12:46
U:RDHL
News Release
200
RedHill Biopharma Announces Closing of $8 Million Registered Direct Offering
2024-01-25 09:05
U:RDHL
News Release
200
RedHill Biopharma Announces $8 Million Registered Direct Offering
2024-01-25 06:00
U:RDHL
News Release
200
RedHill Announces New USPTO Patent Grant for Talicia ‚ ® for H. pylori Treatment Through 2042
2023-12-20 08:45
U:RDHL
News Release
200
RedHill and U.S. Army Announce Opaganib and RHB-107 Combinations with Remdesivir Show Distinct Synergistic Effect Against Ebola
2023-12-12 07:00
U:RDHL
News Release
200
RedHill Biopharma Regains Compliance with Nasdaq Minimum Bid Price Requirement
2023-12-04 07:00
U:RDHL
News Release
200
RedHill Announces New, Non-Dilutive External Funding of Entire RHB-107 COVID-19 300-Patient Phase 2 Study
2023-11-27 07:00
U:RDHL
News Release
200
RedHill Biopharma Announces FDA Grant of 5-Year U.S. Market Exclusivity for Talicia ‚ ® with IP Protection Running to 2034
2023-11-14 08:00
U:RDHL
News Release
200
RedHill Biopharma Announces the Transfer of its Listing to The Nasdaq Capital Market
2023-10-03 07:00
U:RDHL
News Release
200
RedHill and U.S. Army Announce Opaganib's Ebola Virus Disease Survival Benefit in U.S. Army-Funded In-Vivo Study
2023-09-22 16:15
U:RDHL
News Release
200
RedHill Biopharma Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency
2023-09-18 07:00
U:RDHL
News Release
200
RedHill Announces FDA sNDA Approval for Talicia ‚ ®
2023-09-05 07:00
U:RDHL
News Release
200
RedHill Announces New USPTO Notice of Patent Allowance for Opaganib and EU Patent Grant for RHB-102 (BEKINDA ‚ ®)
2023-08-17 07:00
U:RDHL
News Release
200
RedHill Biopharma Provides H1/23 Financial Results and Operational Highlights
2023-08-01 07:00
U:RDHL
News Release
200
RedHill Biopharma Announces Talicia Approved in the United Arab Emirates and First Commercial Order Outside the U.S.